Turnover
≈ €82,000 estimated
The micro format states no turnover.
GLARNER
Lifetime
2 annual accounts with figures on one time axispeak €78,132 (2024)
€27,092▼ 65.3%
peak €62,994 (2024)
€20,083▼ 68.1%
peak €65,577 (2025)
€65,577▲ 15.6%
€48,367▼ 35.4%
Board1 name since 2024
1 directorGLARNER Sylvain-Dieudonné
Documentsfilings and deeds
04-05-20264 days late
2025micro format
Gross margin from €78,132 to €27,092Result from €62,994 to €20,083Equity from €56,744 to €65,577Debts from €74,878 to €48,367Investments €1,798
Key points
from the 2025 annual accountsInvestments
€1,798 2.5 × depreciation
Green is investment, beige is depreciation.
Liquidity
2.30 was 1.73 in 2024
Short-term debts fell from €74,878 to €48,367.
2025 accounts filed 4 days after the deadline
Checked score
94
Excellent
Financially stronger than 53% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
03-2025: 0.3%
04-2025: 0.3%● unchanged vs 03-2025highest value
05-2025: 0.3%● unchanged vs 04-2025highest value
06-2025: < 0.1%▼ -0.3 percentage points vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Founded in 2024
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.30, cash €110,451
Size: total assets €113,944
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 46% of them on solvency, 62% on liquidity, 46% on profitability and 59% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-09-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as GLARNER has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of GLARNER itself is lower: < 0.1% within 12 months. It rests on far more data about GLARNER than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for GLARNER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €6,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 2.3 (1.73 in 2024), above the usual 1.5. Short-term debt is 42.4% and cash 96.9% of total assets. 42.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 4 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 04-05-2026, 4 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filingsDeviation from the deadline
2025
4 days late
2024
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 2 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end10-11-2026 today30-04-2027 deadline
Recent changes
Incorporation
Founding capital of €5,000, 100 shares · Founder: GLARNER Sylvain-Dieudonné (comparant constituant) · Appointment: GLARNER Sylvain-Dieudonné (director) · published on 16-02-2024 · Gazette deed
First establishment
Rue Fariaux 38, Mons
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| GLARNER Mons | €113,944 | €27,092 | 57.6% | - |
| Osteopathie Apolline Ameel Kortrijk | €111,936 | €29,152 | 34.6% | - |
| Niels Ockerman BV Kluisbergen | €114,700 | €29,094 | 79.4% | - |
| Origin Kasterlee | €111,027 | €29,941 | 30.2% | - |
| ANS HUYS Affligem | €108,968 | €28,678 | 65.3% | - |
| Endure Lummen | €113,000 | €24,157 | 72.5% | - |
| DE BUYSER-BAJRAJ Zedelgem | €99,616 | €29,044 | 71.8% | - |
These companies have the same main activity as GLARNER: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €99,600 and €115,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 14-02-2024Normal situation
- Activity
- PhysiotherapyNACE 86951
- Establishment unit
- 2.356.408.8257000 Mons, since 14-02-2024
- Financial year end
- 30 September
- Peppol
- Not found in the Peppol Directory
Insights on GLARNER
GLARNER has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €65,577 and a net result of €20,083.
Its solvency ranks better than 45% of 20,764 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about GLARNER
- What is the company number of GLARNER?
- The company number of GLARNER is 1005.999.173. The VAT number is the same number with BE in front: BE 1005.999.173.
- Where is GLARNER based?
- The registered office is at Rue Fariaux 38, 7000 Mons.Company details
- What does GLARNER do?
- According to the KBO register, the main activity is physiotherapy (NACE 86951).
- What is the legal form of GLARNER?
- GLARNER is a private limited company (BV).
- When was GLARNER founded?
- GLARNER was founded on 14-02-2024.
- Is GLARNER still active?
- Yes, GLARNER is an active enterprise in the KBO register.
- What is the turnover of GLARNER?
- The turnover in financial year 2025 is ≈ €82,000. This figure is estimated from the gross margin of €27,092 and 34 comparable companies (NACE 869). It probably lies between €62,000 and €120,000.Financials
- Is GLARNER profitable?
- In financial year 2025, GLARNER made a profit of €20,083.
- Where can I find the annual accounts of GLARNER?
- GLARNER filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of GLARNER due?
- GLARNER must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.